Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 5/20 | 0.64 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | SOD1 | P00441 | 1/20 | 0.48 |
| ▸ | NAMPT | P43490 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11253238 | 0.92 | TBXAS1 (0.56) | TBXAS1CYP19A1KDM4EHPGDSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL11252177 | 0.91 | TBXAS1 (0.55) | TBXAS1CYP19A1KDM4EHPGDSMN1; SMN2 | |
| Nafimidone SCHEMBL1817018 | 0.84 | ALPG (0.66) | TBXAS1CYP19A1 | |
| SCHEMBL6949512 | 0.84 | TBXAS1 (0.89) | TBXAS1CYP19A1 | |
| Nafimidone SCHEMBL29861032 | 0.83 | ALPG (0.67) | TBXAS1CYP19A1 | |
| Nafimidone SCHEMBL412582 | 0.83 | ALPG (0.67) | TBXAS1CYP19A1 | |
| Hydrochloric Acid SCHEMBL11259498 | 0.82 | TBXAS1 (0.86) | TBXAS1CYP19A1 | |
| Nafimidone SCHEMBL11356554 | 0.82 | ALPG (0.63) | TBXAS1CYP19A1 | |
| SCHEMBL11152430 | 0.81 | TBXAS1 (0.70) | TBXAS1CYP19A1ALDH1A1 | |
| SCHEMBL2436231 | 0.81 | TBXAS1 (0.59) | TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0974584-B1 | FUSED RING COMPOUNDS, PROCESS FOR PRODUCING THE SAME AND USE THEREOF | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-01-15 | — | — | EP | disclosed |
| US-6420375-B1 | ANTITUMOR | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-07-16 | — | — | US | disclosed |
| CN-1251577-A | Fused ring compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2000-04-26 | — | — | CN | disclosed |
| EP-0974584-A1 | FUSED RING COMPOUNDS, PROCESS FOR PRODUCING THE SAME AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2000-01-26 | — | — | EP | disclosed |